Organovo Holdings, Inc. Company
At Organovo, we design and create functional human tissues using our proprietary three-dimensional bioprinting technology. Our goal is to build living human tissues that are proven to function like native tissues. Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.
Funding Status:
IPO
Headquarters:
San Diego
Founded Date:
2007
Employee Number:
Undisclosed
Industry:
Regenerative Medicine
Technology:
Regenerative Medicine - other
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A